ClinicalTrials.gg
CompletedNCT06777576Updated Oct 29, 2026

Self-balancing Personal Exoskeleton for SCI

An interventional study of Hands-free exoskeleton in Spinal Cord Injuries (SCI) and Paraplegia and Tetraplegia, sponsored by Wandercraft. Completed at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Wandercraft · Not applicable, Interventional, and Other

How we know

Updated Oct 29, 2026Now CompletedStudy documents posted+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 968 studies in Spinal Cord Injuries with a site in United States — 249 open to participants now, 308 under way, 7 of them phase 3. Spinal Cord Injuries · United States.

Enrollment
367th of 836
27 · median 24
Started
2025
with 56 others
No phase
601 of 968
189 open now
Registered
857th of 968
by date

Among the 968 studies in Spinal Cord Injuries with a site in United States, this one is the 367th largest by enrollment of the 836 interventional ones that give a count, is one of 57 that started in 2025, is one of 601 with no phase, and was the 857th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

249 of the 968 studies in Spinal Cord Injuries with a site in United States are open now. Recruiting first, the newest first:

244 more — sign in →

All 249 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 968 studies in Spinal Cord Injuries with a site in United States, or all of them as a file.
02

Study summary

This study aims to demonstrate the safety and effectiveness of the Eve personal exoskeleton in individuals with spinal cord injury (SCI).

Read the detailed description

This personal exoskeleton, developed by Wandercraft as a new version of the Atalante X, offers a novel hands-free and self-balancing design, aiming at enhancing stability and mobility for users in daily activities.

The study features an interventional, prospective, single-group, and open-label design, conducted over 3 to 4 weeks at two US research facilities. 24 subjects are required to complete the study. Anticipating a 15% dropout rate, the study will enroll 29 participants.

Over the course of nine to ten scheduled visits, participants undergo a sequence of procedures, beginning with screening and device fitting. This is followed by five training sessions which conclude with an evaluation to issue a competency certificate to confirm the ability to use the device across all its "basic skills". Additionally, two sessions are dedicated to evaluating the exoskeleton's effectiveness outcomes, complemented by an extra practice session. Each visit lasts an average of 1.5 hours.

03

Conditions studied

  • Spinal Cord Injuries (SCI)
  • Paraplegia and Tetraplegia

Keywords

  • Spinal Cord Injury
  • Robotics
  • Hands-free exoskeleton
  • Overground exoskeleton
  • Walking
  • Self-balancing
  • personal use
  • home
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

SCI user inclusion Criteria:

  • Any gender, age 18 years or older;
  • Motor complete or incomplete SCI with lesions at or above T6;
  • ≥ 6 months post SCI;
  • Able and willing to attend 9 to 10 visits1 to the center, including sessions of training and assessments of one-to-three hours duration;
  • Able to read, understand, and provide ;
  • Living in the US and speaks English.

SCI user exclusion Criteria:

  • Diagnosis of neurological injury other than SCI;
  • Progressive condition that would be expected to result in changing neurological status;
  • Severe concurrent medical disease, illness or condition judged to be by the site physician;
  • Unhealed or unstable traumatic or high impact lower extremity fracture of any duration that is, in the clinical judgement of the study physician, exclusionary for standing and walking;
  • Knee (proximal tibia and/or distal femur) BMD \<0.60 gm/cm2;
  • Total hip BMD T-scores \< -3.5;
  • Fragility, minimal trauma, or low impact fracture of the lower extremity since SCI;
  • Untreatable severe spasticity judged to be contraindicated by the site physician;
  • Untreated/uncontrolled hypertension, as judged to be contraindicated by the site physician;
  • Unresolved orthostatic hypotension (change from baseline seated BP to a fall in 20mmHg SBP and/or fall in 10mmHG DBP and symptoms when standing), or as judged to be contraindicated by the site physician;
  • Open or unhealed skin pressure sores, abrasions, or bruises at any of the contact points of the exoskeleton;
  • Morphological contraindications to the use of the device;
  • Uncorrectable leg length discrepancy over 2 cm (about 0.79 in) when using additional correction tools;
  • Unable to effectively operate the device with a hand-control interface, due to functional and/or cognitive impairment, evaluated based on the ability to manipulate the joystick in all direction, press and identify buttons on the hand control interface.
  • Improper fitting in the device;
  • Psychopathology documentation in the medical record that may conflict with study objectives;
  • Pregnancy or women who plan to become pregnant during the study period;
  • Concurrent participation in another interventional trial;
  • History of uncontrolled autonomic dysreflexia;
  • Presence colostomy and/or urostomy;
  • Ventilator use at the time of the exoskeleton use.

Companion inclusion Criteria:

  • Any gender, age 18 years or older;
  • Willingness to attend 9 to 10 visits to the center, including sessions of training and assessments of one-to-three hours duration with the SCI user;
  • Able to read, understand and provide informed consent;
  • Living in the US and speaks English.

Companion exclusion Criteria:

  • Inability to communicate with an assistant due to cognitive and language disorders;
  • Any disease, concomitant injury, or condition that interferes with the performance or interpretation of the protocol- specified assessments;
  • Insufficient strength and performance capability, evidenced by the ability to hold and retain the device in case of unbalance/fall;
  • Insufficient availability to complete the study;
  • Concurrent participation in another interventional trial.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    Hands-free exoskeleton

    Device: Hands-free exoskeleton

Interventions

  • DeviceHands-free exoskeleton

    A "device trainer specialist" from the investigation site will deliver training sessions with the exoskeleton to pair of participants (a pair corresponds to an individual with SCI and his/her companion). The device trainer will follow the progression of the pair through the training program and ensure they learn all the device "basic skills". Each training session lasts an average of 1.5 hours, variations according to the user's learning pace and tolerance. During the sessions with the exoskeleton, the participants will engage in mobility activities on different surfaces and perform Activities of Daily Living in simulated environments such as kitchen, bathroom, elevators and outdoor spaces.

06

What researchers measure

Primary outcomes

  1. Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less.

    The TUG evaluates the time from starting in a seated position to stand-up, walk 3 meters, turn around, walk back 3 meters and sit down on indoor surface.

    Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.

  2. Proportion of subjects who complete a distance of at least 40m on the Six-Minute Walk Test (6MWT).

    The 6MWT measures the distance in meters traversed over 6 min, on indoor surface.

    Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.

Secondary outcomes

  1. Proportion of subjects who can complete at least 4 out of the 6 Activities of Daily Living (ADLs), in various simulated environments and with the exoskeleton.

    The ADLs are done standing in front of the countertop in the kitchen, in a simulated living room, taking a 50m walk in the outdoor environment, taking the elevator, in the bathroom and walking in a hallway and through a door to get to the next room.

    Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.

  2. Proportion of subjects who complete the 10-Meter Walk Test (10MWT) on indoor surfaces in 1 minute or less.

    The 10MWT measures the time in seconds taken to walk 10 meters.

    Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.

  3. Proportion of subjects who can don or doff the device within 10 minutes each, separately.

    Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.

Other outcomes

  1. Proportion of users who pass the device "basic skills" certification evaluation at the end of visit 6.

    During the Certification Evaluation, the users' performance in executing all the device usability critical tasks will be observed and assessed by the trainer to ensure they are performed correctly (i.e., executed safely, regardless of the level of companion assistance, that is documented but isn't a criterion for success). The "basic skills" certification evaluation is passed if all the device basic skills have been learnt through the previous training sessions with the device (visits 2-5) and the critical tasks are re-executed correctly during the evaluation at visit 6. The device basic skills cover device theoretical knowledge, proper setup and installation in the device, walking and other ambulatory functions on different surfaces, Activities of Daily Living in indoor and outdoor environment techniques on various surfaces, and safety features such as emergency extraction.

    Time frame: Throughout the study and up until the end of Visit 6, after an average of 7.5 hours of training.

  2. Number of users who successfully master the different basic skills at a given visit

    For each basic skill, the visit number at which users are confirmed to have safely mastered the task is recorded on a "checklist", which lists all the device basic skills and is provided to the trainer. The goal is to track the users' learning progress and mastery of the device over time.

    Time frame: Throughout the study and up until the end of Visit 6, after an average of 7.5 hours of training.

  3. Evaluation of the assistance level provided by companion.

    Assistance provided by the companion when mastering each basic skill on the checklist at initial learning, at the certification evaluation, during the additional practice session and when performing each test.

    Time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.

  4. Overall Rating of Perceived Exertion (RPE) assessed with the Borg RPE scale by the users for the entire session.

    The Borg scale rates the perceived exertion between 6 and 20 (very very light to very very hard exertion). The SCI users and their companions are asked to give their rating for the entire session, separately.

    Time frame: At the end of visit 6 after an average of 7.5 hours of training, at the end of visit 7 after an average of 7.5 hours of training and 1.5 hours of assessment and at the end of visit 9, after an average of 9 hours of training and 3 hours of assessment.

  5. Overall perceived safety with a 7-level Likert scale by the users on the entire session.

    Each participant - SCI user and companion separately - will be asked to provide his/her level of agreement on the following statement: "I felt safe during the session." by using a 7-level agreement scale from 1: "Strongly disagree" to 7: "Totally agree".

    Time frame: At the end of visit 6 after an average of 7.5 hours of training, at the end of visit 7 after an average of 7.5 hours of training and 1.5 hours of assessment and at the end of visit 9, after an average of 9 hours of training and 3 hours of assessment.

  6. Up-right time in the device at each session

    This measure is taken by the device itself.

    Time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.

  7. Numbers of steps taken in the device at each session

    The measure is taken by the device itself.

    Time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.

  8. Distance walked in the device at each session

    The measure is taken by the device itself.

    Time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.

  9. Number of times the participants walk on each type of surface at each session

    This data is collected by the device trainers at each session. Users are considered to have walked on a surface during a session if they have covered a minimum distance of 10 meters on that surface.

    Time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.

  10. Perceived health benefits and overall satisfaction and motivation.

    Perceived health benefits and overall satisfaction and motivation of the SCI users, assessed by a modified version of the Gagnon questionnaire. The statements under evaluation will be taken from the 41 statements originally found in the Gagnon questionnaire that encompass seven domains : * overall program satisfaction, * satisfaction with the robotic exoskeleton, * learnability of the robotic exoskeleton, * satisfaction with the program attributes, * perceived health benefits of walking with the robotic exoskeleton, * perceived risks and fears of walking with the robotic exoskeleton and * perceived motivation to engage in regular physical activity.

    Time frame: At visit 9, after an average of 9 hours of training and 3 hours of assessment.

07

Study locations

2 sites
  • Kessler Foundation
    West Orange, New Jersey 07052, United States
  • James J. Peters, VA Medical Center, Bronx, NY
    The Bronx, New York 10468-3904, United States
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — The final datasets underlying publications from this research will not be made available to third parties, except as required by applicable law or for review by regulatory authorities and ethics committees.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2025 to primary completion in Jun 2026, 15 months.

Of 49 industry-sponsored interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 28. This study's 15 months is close to that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: primary completion May 2026 → Jun 2026 and completion May 2026 → Jun 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 8, 2025
First posted
Jan 16, 2025
StartActual
Feb 12, 2025
Primary completionActual
Jun 10, 2026was May 2026
CompletionActual
Jun 24, 2026was May 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 15, 2026
Sites
1 site added
Show site
  • Kessler Foundation · West Orange, United States
Oct 29, 2026
Primary completion
May 31, 2026→Jun 10, 2026 (actual)
Oct 15, 2026
Study completion
May 31, 2026→Jun 24, 2026 (actual)
Oct 15, 2026
Enrollment
24 (estimated)→27 (actual)
Oct 15, 2026
Documents
Sponsor
Collaborators added: Kessler Foundation
Oct 29, 2026
Show all 2 updates
  1. Oct 29, 2026
    1 site added
    Show site
    • Kessler Foundation · West Orange, United States
    Sponsor Collaborators added: Kessler Foundation
    + 1 other change: data sharing statement
  2. Oct 15, 2026
    Recruiting→Completed
    Primary completion May 31, 2026→Jun 10, 2026 (now actual)
    Study completion May 31, 2026→Jun 24, 2026 (now actual)
    Enrollment 24 (estimated)→27 (actual)
    + 6 other changes: verification date, description, conditions, contact details, site details and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06777576
Lead sponsor
Wandercraft
Collaborators
James J. Peters Veterans Affairs Medical Center, Kessler Foundation
Responsible party
Sponsor
First posted
Jan 16, 2025
Start date
Feb 12, 2025
Primary completion
Jun 10, 2026
Completion
Jun 24, 2026
Last update
Oct 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion